Pancreatic cancer is the fourth most common cause of cancer-related mortality in Europe.¹ Despite increased awareness, most patients continue to present with advanced disease. There has been minimal improvement in survival rates over the past 30 years, with overall 5-year survival remaining less than 8%.² While these disappointing results are due to a multitude of host and treatment variables, it is apparent that, for a significant number of patients, poor nutritional and performance status are limiting factors to treatment choice, delivery, and tolerance.

中文翻译：

---

少肌症—交界性可切除胰腺癌患者管理护理的新领域

胰腺癌是欧洲与癌症相关的死亡率的第四大最常见原因。¹尽管意识有所增强，但大多数患者仍表现为晚期疾病。在过去的30年中，生存率几乎没有改善，总体5年生存率仍不到8％。²尽管这些令人失望的结果是由于宿主和治疗变量众多，但很明显，对于许多患者而言，营养和表现状况差是限制治疗选择，分娩和耐受性的因素。